ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Methyl iodide → 6-Chloro-4-(1-((4-(4-fluorophenyl)-1-methylpiperidin-4-yl)methoxy)ethyl)-1,3-bis((2-(trimethylsilyl)ethoxy)methyl)-1H-benzo[d]imidazol-2(3H)-one

HRID 913941
印刷

反応式

HRID 913941 の反応式
[Cl:1][C:2]1[CH:3]=[C:4]([CH:21]([O:23][CH2:24][C:25]2([C:38]3[CH:43]=[CH:42][C:41]([F:44])=[CH:40][CH:39]=3)[CH2:30][CH2:29][N:28]([C:31](OC(C)(C)C)=O)[CH2:27][CH2:26]2)[CH3:22])[C:5]2[N:9]([CH2:10][O:11][CH2:12][CH2:13][Si:14]([CH3:17])([CH3:16])[CH3:15])[C:8](=[O:18])[N:7]([CH3:19])[C:6]=2[CH:20]=1.ClC1C=C(C(OCC2(C3C=CC(F)=CC=3)CCN(C(OC(C)(C)C)=O)CC2)C)C2N(C)C(=O)N(C[O:57][CH2:58][CH2:59][Si:60]([CH3:63])([CH3:62])[CH3:61])C=2C=1.ClC1C=C(C(OCC2(C3C=CC(F)=CC=3)CCN(C(OC(C)(C)C)=O)CC2)C)C2NC(=O)N(COCC[Si](C)(C)C)C=2C=1.ClC1C=C(C(OCC2(C3C=CC(F)=CC=3)CCN(C(OC(C)(C)C)=O)CC2)C)C2N(COCC[Si](C)(C)C)C(=O)NC=2C=1.[H-].[Na+].IC>CN(C)C=O>[Cl:1][C:2]1[CH:3]=[C:4]([CH:21]([O:23][CH2:24][C:25]2([C:38]3[CH:39]=[CH:40][C:41]([F:44])=[CH:42][CH:43]=3)[CH2:26][CH2:27][N:28]([CH3:31])[CH2:29][CH2:30]2)[CH3:22])[C:5]2[N:9]([CH2:10][O:11][CH2:12][CH2:13][Si:14]([CH3:16])([CH3:17])[CH3:15])[C:8](=[O:18])[N:7]([CH2:19][O:57][CH2:58][CH2:59][Si:60]([CH3:63])([CH3:62])[CH3:61])[C:6]=2[CH:20]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 6

HCID 6328Methyl iodideHCID 24758Sodium hydrideHCID 57546103Tert-butyl 4-((1-(6-chloro-2-oxo-3-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1h-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylateHCID 57546155Tert-butyl 4-((1-(6-chloro-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1h-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate
HCID 57546159
tert-Butyl 4-((1-(6-chloro-1-methyl-2-oxo-3-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate
3 回
HCID 57546215tert-Butyl 4-((1-(6-chloro-3-methyl-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate3 回

生成物 1

HCID 575459266-Chloro-4-(1-((4-(4-fluorophenyl)-1-methylpiperidin-4-yl)methoxy)ethyl)-1,3-bis((2-(trimethylsilyl)ethoxy)methyl)-1H-benzo[d]imidazol-2(3H)-one

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

反応条件

温度
0 °C

実験手順

tert-Butyl 4-((1-(6-chloro-1-methyl-2-oxo-3-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate and tert-Butyl 4-((1-(6-chloro-3-methyl-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate (2:1). To a solution of tert-Butyl 4-((1-(6-chloro-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate and tert-Butyl 4-((1-(6-chloro-2-oxo-3-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate (2:1) (84 mg, 0.066 mmol) in dimethylformamide (1 mL) at 0° C. was added sodium hydride (9.5 mg, 0.40 mmol). To this was quickly added iodomethane (0.033 mL, 0.53 mmol). After stirring at 0° C. for 15 min, the reaction was quenched by addition of saturated ammonium chloride. The mixture was diluted with diethyl ether and water and the layers separated. The ethereal was washed with water (2×), then brine, dried over magnesium sulfate, and concentrated. Column chromatography (25%→37% ethyl acetate/n-hexane) gave separation of the two isomers. The first to elute was tert-butyl 4-((1-(6-chloro-1-methyl-2-oxo-3-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate (major) (53 mg, 0.082 mmol, 62%). The second to elute was tert-Butyl 4-((1-(6-chloro-3-methyl-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate (minor) (26 mg, 0.040 mmol, 30%). tert-Butyl 4-((1-(6-chloro-1-methyl-2-oxo-3-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate: 1H-NMR (CDCl3, 500 MHz) δ 7.21 (dd, J=8.9, 5.2 Hz, 2H), 6.97 (dd, J=8.9, 8.5 Hz, 2H), 6.81 (d, J=2.1 Hz, 1H), 6.75 (d, J=1.2 Hz, 1H), 5.36 (d, J=1 1.6 Hz, 1H), 5.04 (d, J=11.3 Hz, 1H), 4.95 (q, J=6.4 Hz, 1H), 3.68 (m, 2H), 3.51 (t, J=8.2 Hz, 2H), 3.35 (s, 2H), 3.20 (d, J=9.2 Hz, 1H), 3.18 (d, J=9.2 Hz, 1H), 3.01 (m, 2H), 2.07 (m, 2H), 1.83 (m, 2H), 1.42 (s, 9H), 1.34 (d, J=6.4 Hz, 3H), 0.72-0.92 (m, 2H), −0.05 (s, 9H); 13C NMR (126 MHz, CDCl3) δ ppm 161.4 (d, J=245 Hz), 155.0, 154.9, 138.7, 138.6, 131.7, 128.7 (d, J=7.7 Hz), 128.3, 128.0, 124.4, 119.4, 115.1 (d, J=21 Hz), 106.9, 104.2, 79.4, 76.7, 71.5, 71.4, 65.9, 41.1, 40.1, 32.2, 32.1, 28.5, 27.4, 23.2, 18.1, −1.4. tert-Butyl 4-((1-(6-chloro-3-methyl-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydro-1H-benzo[d]imidazol-4-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate: 1H-NMR (CDCl3, 500 MHz) δ 7.24 (dd, J=8.9, 5.2 Hz, 2H), 7.01 (m, 3H), 6.76 (d, J=2.1 Hz, 1H), 5.23 (s, 2H), 4.75 (q, J=6.4 Hz, 1H), 3.72 (bs, 2H), 3.58 (t, J=8.2 Hz, 2H), 3.43 (s, 3H), 3.27 (d, J=8.9 Hz, 1H), 3.17 (d, J=9.2 Hz, 1H), 3.00 (m, 2H), 2.11 (m, 2H), 1.83 (m, 2H), 1.43 (s, 9H), 1.38 (d, J=6.4 Hz, 3H), 1.25 (m, 2H), 0.91 (m, 2H), −0.04 (s, 9H); 13C NMR (126 MHz, CDCl3) δ ppm 161.5 (d, J=246 Hz), 155.0, 154.7, 138.43, 138.41, 130.3, 128.7 (d, J=7.7 Hz), 127.4, 127.2, 125.7, 120.0, 115.2 (d, J=21 Hz), 108.4, 104.3, 79.5, 77.6, 73.1, 71.0, 66.5, 41.2, 40.1 (br), 32.3, 32.1, 30.6, 28.6, 23.8, 17.9, −1.4.

後処理

  1. customthe reaction was quenched by addition of saturated ammonium chloride
  2. additionThe mixture was diluted with diethyl ether and water
  3. customthe layers separated
  4. washThe ethereal was washed with water (2×)
  5. dry with materialbrine, dried over magnesium sulfate
  6. concentrationconcentrated
  7. customColumn chromatography (25%→37% ethyl acetate/n-hexane) gave
  8. customseparation of the two isomers
  9. washThe first to elute
  10. washThe second to elute

出典と根拠

ORDレコード
ord-01373c2b92b74664a37ed1a8027a9059
出典データセット
uspto-grants-2011_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08026257B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート